1. Home
  2. USLM vs EVO Comparison

USLM vs EVO Comparison

Compare USLM & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

HOLD

Current Price

$127.62

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.64

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USLM
EVO
Founded
1948
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
USLM
EVO
Price
$127.62
$3.64
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
83.3K
255.2K
Earning Date
02-02-2026
11-05-2025
Dividend Yield
0.19%
N/A
EPS Growth
32.23
N/A
EPS
4.55
N/A
Revenue
$364,849,000.00
$887,396,457.00
Revenue This Year
$22.64
N/A
Revenue Next Year
$8.38
$8.52
P/E Ratio
$27.99
N/A
Revenue Growth
20.27
N/A
52 Week Low
$80.47
$2.84
52 Week High
$137.96
$4.80

Technical Indicators

Market Signals
Indicator
USLM
EVO
Relative Strength Index (RSI) 56.21 71.15
Support Level $118.57 $3.10
Resistance Level $129.09 $3.23
Average True Range (ATR) 4.10 0.08
MACD -0.15 0.07
Stochastic Oscillator 69.71 98.73

Price Performance

Historical Comparison
USLM
EVO

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: